1-7 of 7
Grace Bosma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TP53 -Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes By Treatment Modality: A Multicenter Cohort from 14 U.S. Centers

Cassandra Duarte, Grace Bosma, Diana Abbott, Gaston Jean-Louis, Maciej Kabat, Daniel Stapor, Nancy Musoke, Brian T. Hill, Alexander Gorzewski, Tharakeswari Selvakumar, Asaad Trabolsi, Megan Greenberg, Alec Hansen, Neil Bailey, Mazyar Shadman, Ellen K Kendall, Nausheen Ahmed, Forat Lutfi, Patrick Connor Johnson, Mengyang Di, Krish Patel, Allison M. Bock, Joanna Rhodes, Jonathan H. Schatz, Brian Hess, Reem Karmali, Zachary AK Frosch, Andrew Ip, Hua-Jay J Cherng, Jagar Jasem, Steven M. Bair, Bradley M. Haverkos, Manali Kamdar, Ajay Major
Journal: Blood
Blood (2024) 144 (Supplement 1): 6451.
https://doi.org/10.1182/blood-2024-194844
Published: 2024
Journal Articles

Treatment-Related and De Novo Ccus Have Similar Molecular Features and Risk of Progression to Myeloid Malignancies

Jennifer Santos, Diana Abbott, Grace Bosma, Andrew Kent, Marc Schwartz, Christine M. McMahon, Jonathan Gutman, Daniel A Pollyea, Maria L Amaya
Journal: Blood
Blood (2024) 144 (Supplement 1): 5649.
https://doi.org/10.1182/blood-2024-201062
Published: 2024
Journal Articles

Efficacy and Molecular Predictors of Response and Survival for Venetoclax/Azacitidine Therapy in Relapsed or Refractory Acute Myeloid Leukemia

Jason S. Gilbert, Megan Connor, Grace Bosma, Christine M. McMahon, Maria L Amaya, Jonathan Gutman, Marc Schwartz, Andrew Kent, Diana Abbott, Daniel A Pollyea
Journal: Blood
Blood (2024) 144 (Supplement 1): 4266.
https://doi.org/10.1182/blood-2024-199862
Published: 2024
Journal Articles

Clinical and Molecular Features of Highly Durable Response to Azacitidine+Venetoclax in Acute Myeloid Leukemia

Alexander Hayden, Grace Bosma, Jonathan A. Gutman, Maria L. Amaya, Diana Abbott, Clayton Smith, Brett M. Stevens, Craig T. Jordan, Daniel A. Pollyea, Christine M. McMahon
Journal: Blood
Blood (2022) 140 (Supplement 1): 9163–9164.
https://doi.org/10.1182/blood-2022-171064
Published: 2022
Journal Articles

Overall Survival and Its Interplay with Allogeneic Stem Cell Transplant and Age in Newly Diagnosed AML Patients Treated with Ven/Aza

Diana Abbott, Grace Bosma, Christine M. McMahon, Marc Schwartz, Jonathan A. Gutman, Daniel A. Pollyea
Journal: Blood
Blood (2022) 140 (Supplement 1): 6181–6182.
https://doi.org/10.1182/blood-2022-169026
Published: 2022
Journal Articles

Response to Intensive Induction Chemotherapy after Failure of Frontline Azacitidine+Venetoclax in Acute Myeloid Leukemia

Christine M. McMahon, Kellen Gil, Maria L. Amaya, Jonathan A. Gutman, Alexander Hayden, Marc Schwartz, Grace Bosma, Diana Abbott, Brett M. Stevens, Clayton Smith, Craig T Jordan, Daniel A. Pollyea
Journal: Blood
Blood (2022) 140 (Supplement 1): 6185–6186.
https://doi.org/10.1182/blood-2022-170168
Published: 2022
Journal Articles

Outcomes Are Similar Following Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Patients Who Received Venetoclax + Azacitidine Versus Intensive Chemotherapy

Amanda C. Winters, Grace Bosma, Diana Abbott, Mohd Minhajuddin, Craig T Jordan, Daniel A. Pollyea, Jonathan A. Gutman
Journal: Blood
Blood (2021) 138 (Supplement 1): 3957.
https://doi.org/10.1182/blood-2021-154392
Published: 2021